Application of Basic Neuroscience to Child Psychiatry

  • Stephen I. Deutsch
  • Abraham Weizman
  • Ronit Weizman

Table of contents

  1. Front Matter
    Pages i-xx
  2. Introduction

    1. Stephen I. Deutsch, Abraham Weizman, Ronit Weizman
      Pages 1-5
  3. Basic Neuroscience Considerations

    1. Front Matter
      Pages 7-7
    2. Roland D. Ciaranello, Dona Lee Wong, John L. R. Rubenstein
      Pages 9-32
    3. Ann M. Rasmusson, Mark A. Riddle, James F. Leckman, George M. Anderson, Donald J. Cohen
      Pages 33-59
    4. Stephen I. Deutsch, Abraham Weizman, Ronit Weizman, Frank J. Vocci Jr., Karin A. Kook
      Pages 61-76
    5. Richard L. Hauger, Itzchak Angel, Aaron Janowsky, Paul Berger, Bridget Hulihan-Giblin
      Pages 77-100
    6. Curt A. Sandman, Abba J. Kastin
      Pages 101-124
    7. John Mastropaolo, Anthony L. Riley
      Pages 125-140
    8. Ronit Weizman, Lynn H. Deutsch, Stephen I. Deutsch
      Pages 153-160
    9. Abraham Weizman, Frank J. Vocci Jr.
      Pages 161-164
    10. Stephen I. Deutsch, Lynn H. Deutsch, Ronit Weizman
      Pages 165-180
  4. Application to Specific Clinical Disorders

    1. Front Matter
      Pages 181-181
    2. J. Gerald Young, James R. Brasic, Len Leven
      Pages 183-216
    3. Wayne H. Green, Stephen I. Deutsch
      Pages 217-229
    4. Ronit Weizman, Abraham Weizman, Stephen I. Deutsch
      Pages 231-239
    5. Phillip B. Chappell, James F. Leckman, David Pauls, Donald J. Cohen
      Pages 241-260
    6. Elizabeth V. Koby
      Pages 261-274
    7. Nelson Freimer, Myrna M. Weissman
      Pages 285-296
    8. Theodore Page, William L. Nyhan
      Pages 297-311
    9. Boris Birmaher, Laurence L. Greenhill, Michael Stanley
      Pages 313-324
    10. Ausma Rabe, Krystyna E. Wisniewski, Nicole Schupf, Henryk M. Wisniewski
      Pages 325-340
  5. Evaluation, Drug Development, and Ethical Considerations

    1. Front Matter
      Pages 341-341
    2. Wilma G. Rosen
      Pages 343-356
    3. Jonathan H. Pincus
      Pages 357-368
    4. Frank J. Vocci Jr, Stephen I. Deutsch
      Pages 369-382
    5. Susan K. Theut, Arthur F. Kohrman
      Pages 383-389
  6. Back Matter
    Pages 391-400

About this book


The idea for this book developed during the course of several discussions among the editors while we were working together as staff scientists in the laboratories of the Clinical Neuro­ science Branch of the National Institute of Mental Health. It was a happy coincidence that the three of us, child psychiatrists with predominantly clinical interests, selected a collaborative bench research project involving neurotransmitter receptor characterization and regulation. We appreciated the relevance of our work to child psychiatry and wished for a forum to share the excitement we enjoyed in the laboratory with our clinical colleagues. Moreover, it seemed to us that much of the pharmacological research in child psychiatry proceeded on an empirical basis, often without a compelling neurochemical rationale. This could reflect the paucity of neurochemical data that exists in child psychiatry and the very limited understanding of the pathophysiology in most psychiatric disorders that occur in childhood. Also, we bemoaned the fact that there was a virtual absence of meaningful interchange between clinical investigators in child psychiatry and their colleagues in the neurosciences. We believed that an edited book appealing to clinicians and basic scientists could serve as an initial effort to foster interchange between them. The editors wish to emphasize that this book is viewed as only a beginning in the process of interchange that must take place.


Assessment Depression Intervention Methylphenidat Nervous System Neuroscience Syndrom attention genetics neuropsychology psychiatry

Editors and affiliations

  • Stephen I. Deutsch
    • 1
    • 2
  • Abraham Weizman
    • 3
  • Ronit Weizman
    • 3
  1. 1.Veterans Administration Medical CenterUSA
  2. 2.Georgetown University School of MedicineUSA
  3. 3.Tel Aviv UniversityTel AvivIsrael

Bibliographic information